Lignans as multi-targeted natural products in neurodegenerative diseases and depression: Recent perspectives

Phytother Res. 2023 Dec;37(12):5599-5621. doi: 10.1002/ptr.8003. Epub 2023 Sep 5.

Abstract

As the global population ages, the treatment of neurodegenerative diseases is becoming more and more important. There is an urgent need to discover novel drugs that are effective in treating neurological diseases. In recent years, natural products and their biological activities have gained widespread attention. Lignans are a class of metabolites extensively present in Chinese herbal medicine and possess good pharmacological effects. Latest studies have demonstrated their neuroprotective pharmacological activity in preventing acute/chronic neurodegenerative diseases and depression. In this review, the pharmacological effects of these disorders, the pharmacokinetics, safety, and clinical trials of lignans were summarized according to the scientific literature. These results proved that lignans mainly exert antioxidant and anti-inflammatory activities. Anti-apoptosis, regulation of nervous system functions, and modulation of synaptic signals are also potential effects. Despite the substantial evidence of the neuroprotective potential of lignans, it is not sufficient to support their use in the clinical management. Our study suggests that lignans can be used as prospective agents for the treatment of neurodegenerative diseases and depression, with a view to informing their further development and utilization.

Keywords: lignans; mechanism; neuroprotection; pharmacokinetics; safety.

Publication types

  • Review

MeSH terms

  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Depression / drug therapy
  • Humans
  • Lignans* / pharmacology
  • Lignans* / therapeutic use
  • Neurodegenerative Diseases* / drug therapy
  • Prospective Studies

Substances

  • Lignans
  • Biological Products